As of 2024-12-11, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 13.8x | 12.3x |
| Forward P/E multiples | 19.2x - 31.2x | 20.6x |
| Fair Price | (11.92) - (10.05) | (10.97) |
| Upside | -178.1% - -165.9% | -171.9% |
| Date | EV/EBITDA |